Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE)

March 2, 2021 updated by: Nancy Latham, Brigham and Women's Hospital

Randomized Trial of a Multifactorial Fall Injury Prevention Strategy

The aim of this pragmatic cluster-randomized trial is to determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy in community dwelling older adults at risk of falls recruited from 86 primary care practices around the U.S.

Study Overview

Detailed Description

Objective: To determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy implemented within primary care practices using usual health care resources

Design: This study is a cluster randomized, parallel group superiority trial with practices stratified by healthcare system and patients nested within practices. The unit of randomization is the practice.

Study Duration: The total study duration is 5 years. Recruitment will take place over 20 months, with follow-up taking place for 24 months - 44 months depending on date of enrollment.

Trial Sites: 86 primary care practices that are part of 10 trial sites located around the U.S.: The Partners' Health Care System; Essentia; Hopkins Health Care System; HealthCare Partners; Reliant Health Care System; Mount Sinai Health Care System; University of Pittsburgh Health Care System; University of Texas Medical Branch Health Care System; University of Iowa Health Care System; University of Michigan Health Care System.

Number of Subjects: The original target sample size was 6,000 participants enrolled in 86 practices to provide 90% power to detect a 20% reduction in the rate of the primary outcome with intervention relative to control. The study was originally designed for a study duration of 36 months with 18 months of recruitment and a minimum of 18 months of follow-up. The study was extended to a 44 month study (20 months of recruitment and a minimum 24 month of follow-up). For a 44 month trial, it was estimated that a sample size of 5,322 subjects would provide 90% power to detect a 20% reduction in the rate of the primary outcome with the intervention relative to control.

Main Inclusion Criteria Community-living persons, 70 years or older, who are at increased risk for serious fall injuries.

Intervention: An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the Center for Disease Control's (CDC's) "STEADI" toolbox (Stopping Elderly Accidents, Disability and Injury) and the joint American Geriatrics Society/British Geriatrics Society guidelines, and Assessing Care of Vulnerable Elders (ACOVE) practice change approach. The fall prevention strategies will be systematically implemented into clinical practice using: delivery system design to improve quality (Co-management); decision support (algorithms); information systems (software); self-management support (patient/caregiver engagement and activation); and linkage to community-based resources.

Primary Outcome: The primary outcome is adjudicated serious fall injuries, operationalized as a fall resulting in: (1) (fracture other than thoracic/lumbar vertebral; joint dislocation; or cut requiring closure) AND any medical attention; OR (2) (head injury; sprain or strain; bruising or swelling; or other) requiring hospitalization.

Primary Analysis: The risk of any serious fall injury (i.e., time to first event) will be analyzed using a survival model that incorporates competing risks (due to death) and clustering. In this analysis, participants who are lost to follow-up without a prior serious fall-related injury will be censored at their date last seen. In a sensitivity analysis, the investigators will adjust for the pre-specified set of baseline covariates to examine their influence on the intervention effect.

Secondary Outcomes: All self-reported falls, all self-reported fall-related injuries, and measures of well-being.

Study Type

Interventional

Enrollment (Actual)

5451

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Torrance, California, United States
        • HealthCare Partners
    • Iowa
      • Des Moines, Iowa, United States
        • University of Iowa Health Alliance
    • Maryland
      • Baltimore, Maryland, United States
        • Johns Hopkins Medicine
    • Massachusetts
      • Boston, Massachusetts, United States
        • Partners HealthCare
      • Worcester, Massachusetts, United States
        • Reliant Medical Group
    • Michigan
      • Ann Arbor, Michigan, United States
        • University of Michigan
    • Minnesota
      • Duluth, Minnesota, United States
        • Essentia Health
    • New York
      • New York, New York, United States
        • Mt Sinai Health System
    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States
        • University of Pittsburgh
    • Texas
      • Galveston, Texas, United States
        • University of Texas Medical Branch at Galveston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The patient is at least 70 years of age.
  • The patient must answer 'yes' to one or more of the following questions:
  • Have you fallen and hurt yourself in the past year?
  • Have you fallen 2 or more times in the past year?
  • Are you afraid that you might fall because of balance or walking problems?

Exclusion Criteria:

  • The patient is enrolled in hospice.
  • The patient resides in a nursing home.
  • The patient is not capable of providing informed consent (or assent), and a proxy is not available.
  • The patient does not speak English or Spanish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Fall prevention standard of care
An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's "STEADI" toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach
Other: Control
Usual fall prevention care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First Adjudicated Serious Fall-Related Injury
Time Frame: Enrollment through last completed follow-up or death interview (max 44 months)
Number of first adjudicated serious fall-related injury serious fall-related injury events per 100 per years of follow-up.
Enrollment through last completed follow-up or death interview (max 44 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First Self-reported Fall-related Injury
Time Frame: Enrollment through last completed follow-up or death interview (max 44 months)
Number of first self-reported fall-related injuries per 100 per years of follow-up
Enrollment through last completed follow-up or death interview (max 44 months)
Time to Self-reported Falls
Time Frame: these data were not collected
** data for this outcome was not collected
these data were not collected
Physical Function
Time Frame: measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores
Late Life Function and Disability Instrument (LL-FDI) function score. The scores are on a 0-100 scale, higher score = better function. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment
measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores
Disability
Time Frame: measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores
Late Life Function and Disability Instrument (LL-FDI) disability score. The scores are on a 0-100 scale, higher score = less disability. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment
measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores
Anxiety
Time Frame: Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.
Patient-reported Outcome Measure Information System (PROMIS) Anxiety subscale. Measured on a 8-40 Scale, higher score = more anxiety.
Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.
Depression
Time Frame: Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.
PROMIS depression subscale. Measured on a 8-40 Scale, higher score = more depression.
Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.
Fear of Falling
Time Frame: Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.
Falls Efficacy Scale. Measured on a 10-40 Scale, higher score = more fear of falling.
Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2015

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

January 1, 2020

Study Registration Dates

First Submitted

June 1, 2015

First Submitted That Met QC Criteria

June 16, 2015

First Posted (Estimate)

June 19, 2015

Study Record Updates

Last Update Posted (Actual)

March 3, 2021

Last Update Submitted That Met QC Criteria

March 2, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • U01AG048270 (U.S. NIH Grant/Contract)
  • 1U01AG048270-01 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wounds and Injuries

Clinical Trials on Usual care

Subscribe